Acacia Pharma Says MAA For BARHEMSYS Under Formal Review In Major European Markets

Acacia Pharma Group plc, a commercial stage biopharmaceutical company, announced Wednesday that its marketing authorization application or MAA for BARHEMSYS (amisulpride injection) has been submitted, validated and is now under formal review in major European markets.

The review process is expected to be completed by the third quarter of fiscal 2022.

BARHEMSYS is a selective dopamine-2 or D2 and dopamine-3 or D3 receptor antagonist, which Acacia Pharma has developed and protected for the management of postoperative nausea & vomiting or PONV.

BARHEMSYS was approved in February 2020 by the Food and Drug Administration for use in the United States to prevent and treat postoperative nausea & vomiting or PONV. It became commercially available in August 2020.

The MAA submission includes data from four positive Phase 3 studies investigating BARHEMSYS. This includes the first ever randomized, controlled trial to show successful treatment of active PONV in patients who have failed prior prophylaxis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla CEO Elon Musk announced that the luxury electric vehicle maker has started the production of Tesla Semi electric trucks, and the first delivery will be to food and beverages giant Pepsico Inc. starting December 1. In a tweet, Musk said, "Excited to announce start of production of Tesla Semi Truck with deliveries to @Pepsi on Dec 1st!" Ford Motor is increasing the entry-level price of its electric F-150 Lightning pickup citing rising costs and supply chain issues amid increasing demand. This is the second price hike after a recent increase in August. The starting price of the 2023 model year pickup will be raised by $5,000 by October 24, reports said citing an email statement. Constellation Brands, Inc. (STZ) said it delivered another quarter of strong business performance. Beer Business achieved double-digit net sales growth for the quarter, while Wine and Spirits net sales rose 1%. The solid top-line performance of its Beer and Wine and Spirits Businesses in the first half...
Follow RTT